洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

会议地点
2024 CPHI & PMEC制药工业展(深圳)
已结束
CPHI深圳展实验室巨头齐聚,共促医药行业技术革新 行业领域: 医药行业、实验室建设 会议类型: 制药工业展、行业峰会、商贸对接会 会议主题: 政策驱动市场扩容,实验室企业助力医药产业发展,推动技术革新 会议名称: CPHI & PMEC制药工业展(深圳) 基本信息 参展时间: 2024年9月9日至2024年9月11日 展会地点: 中国广东省深圳市 主办单位: 上海博华国际展览有限公司 协办单位: 动脉网 联系方式: 展位及广告咨询:张女士,电话:021-33392410,邮箱:Sharon.Zhang@imsinoexpo.com 观众及媒体咨询:林女士,电话:021-33392105,邮箱:Ashley.Lin@imsinoexpo.com 精选展商及产品推荐 | 公司名称                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
深圳市 | 会展中心
2024.09.0909.11
Medtec China 2024暨第十八届国际医疗器械设计与制造技术展览会
已结束
Medtec China 2024暨第十八届国际医疗器械设计与制造技术展览会 行业领域: 医疗器械设计与制造 会议类型: 国际医疗器械设计与制造技术展览会 会议主题: 汇聚全球医疗器械设计与制造领域的创新技术与解决方案 会议名称: Medtec China 2024暨第十八届国际医疗器械设计与制造技术展览会 基本信息 参展时间: 2024年9月25日至2024年9月27日 展会城市: 中国上海市 详细地址: 上海世博展览馆1&2号馆 展馆名称: 上海世博展览馆 主办单位: Informa Markets 承办单位: 协办单位: 联系单位: Informa Markets 联 系 人: Linc Cai 蔡锋 (参展商咨询), Carina Li 李娜 (研讨会咨询/参观咨询/媒体联系) 邮件地址: Linc.Cai@informa.com (参展商咨询), Carina.li@informa.com (研讨会咨询/参观咨询/媒体联系) 联系电话: +86 21 6157 7217 (参展商咨询), +86 10 6562 3308 (研讨会咨询/参观咨询/媒体联系) 联系传真: 展会规模: 42,000 m² (预计) 展商数量: 1000+ 家参展商来自22个国家和地区 观众数量: 80,000+ 人次,来自 9,000+ 家公司,近70 % 观众首次参观 专题论坛: 25+ 场专题研讨,100+ 位特邀嘉宾 演讲活动: 120+ 场演讲 参会代表数量: 4,000+ 名 展品范围 研发和设计服务 体外诊断 计算机和软件 净化室和环境控制 材料制造设备 粘结剂及粘结产品 塑膜成型服务与设备 部件 合同制造服务 电子元件、组件和附件 管件和挤压加工 电机和运动控制 表面处理 泵和阀门 制药设备和服务 过滤器和静脉注射产品 印刷、标签和条码 测试、计量、检验和校准设备及用品 咨询服务 包装和消毒 同期活动 法规讲堂 第七届医疗器械市场分析报告 质量聚焦 高端有源概念论坛 创新技术论坛和法规峰会 行业教育系列活动 参会信息 参展商咨询: Linc Cai 蔡锋 电话:+86 21 6157 7217 邮箱:Linc.Cai@informa.com 研讨会咨询/参观咨询/媒体联系: Carina Li 李娜 电话:+86 10 6562 3308 邮箱:Carina.li@informa.com
上海市 | 上海世博展览馆1&2号馆
2024.09.2709.29
2024冷泉港亚洲会议:睡眠的功能与调节
已结束
2024 Cold Spring Harbor Asia Sleep Research Conference 基本信息 会议网址: https://www.csh-asia.org/?content/2339 会议日期: 2024年9月9日至2024年9月13日 会议地点: 苏州▪独墅湖世尊酒店 会议主题 Sleep Regulation: Circuits and Homeostasis Sleep Regulation: Molecules and Circadian Rhythms Sleep Functions Functions and Regulation of REM Sleep Sleep-Related Disorders and Translational Research 科学组委会成员 Shumin Duan, Zhejiang University Masashi Yanagisawa, University of Tsukuba Maiken Nedergaard, University of Rochester Antoine Adamantidis, University of Bern Min Xu, Chinese Academy of Sciences 特邀演讲嘉宾 Antoine Adamantidis, University of Bern Yang Dan, University of California, Berkeley Luis de Lecea, Stanford University Shumin Duan, Zhejiang University Ying-Hui Fu, University of California, San Francisco Hiromasa Funato, University of Tsukuba Zhili Huang, Fudan University Qinghua Liu, National Institute of Biological Sciences, Beijing Maiken Nedergaard, University of Rochester David Prober, California Institute of Technology Louis Ptacek, University of California, San Francisco Niels Rattenborg, Max Planck Institute for Biological Intelligence Takeshi Sakurai, University of Tsukuba Paul Shaw, Washington University in St. Louis Hiroki Ueda, RIKEN Liping Wang, Chinese Academy of Sciences Min Xu, Chinese Academy of Sciences Akihiro Yamanaka, Chinese Institute for Brain Research, Beijing Masashi Yanagisawa, University of Tsukuba Hayashi Yu, University of Tokyo Erqian Zhang, National Institute of Biological Sciences, Beijing 参会/参展咨询 联系单位: Cold Spring Harbor Asia 地址: No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China 电话: +86-512-62729029-1301 传真: +86-512-62729028 邮箱: mikeji@csh-asia.org 网站: www.csh-asia.org
苏州市 | 独墅湖世尊酒店
2024.09.0909.13
共话肿瘤免疫壮丽里程 —— I-O Asia 2024亚洲肿瘤诊疗与药物创新峰会9月广州启程
已结束
2024亚洲肿瘤诊疗与药物创新峰会(I-O Asia 2024) 行业领域: 肿瘤免疫治疗、癌症研究、临床医学 会议类型: 峰会、学术会议、行业论坛 会议主题: 探讨肿瘤免疫治疗领域的前沿进展,推动癌症诊疗技术创新 会议名称: 2024亚洲肿瘤诊疗与药物创新峰会(I-O Asia 2024) 基本信息 主办单位: 谈思生物 协办单位: 广东医谷 举办时间: 2024年9月26日至27日 举办地点: 广州 会议议程概览 肿瘤免疫治疗的机遇、挑战与未来 流式细胞术在转化医学中的现在与展望 ADC药物在肿瘤治疗中的应用 基于CD73靶点的创新型抗体偶联药物开发 直肠癌的转化治疗:药物联合治疗的疗效与安全性 泛瘤种治疗进行时,创新ADC技术平台推动肿瘤治疗升维变革 同时靶向CD40和4-1BB信号通路的双特异性抗体研发与在肿瘤治疗中的应用 肿瘤免疫治疗药物研发的临床转化挑战与策略 HER2靶点双抗ADC药物治疗非小细胞肺癌的开发进展与临床 生物标志物精准指导下的抗肿瘤药物临床研究 特色亮点 汇聚全球顶尖科研人员、临床医生、制药企业等专业人士 共同探讨和推动肿瘤免疫治疗发展 诚邀各界人士共同参与,共同书写肿瘤免疫治疗的新篇章 参会信息 注册咨询:https://s.wcd.im/v/4hglcZe0/ 演讲、赞助、参展&市场与媒体合作: 闫女士 手机:133 4168 3667 微信:taaslabs-bio 邮件:Koala.yan@taaslabs.com 官网:https://genetherapy-asia.taaslabs.com/
广州市 | 广州
2024.09.2609.27
2024华南国际制药机械展览会
已结束
2024广州琶洲国际制药装备展览会 行业领域: 制药装备产业、生物医药产业 会议类型: 博览会、展览会、行业峰会、商贸对接会 会议主题: 立足大湾区,辐射全国,打造制药装备行业盛会,促进国内外制药装备行业交流合作 基本信息 参展时间: 2024年9月8日至2024年9月10日 展会城市: 中国广东省广州市 详细地址: 广州琶洲保利世贸博览馆 展馆名称: 广州琶洲保利世贸博览馆 主办单位: [主办单位名称] 承办单位: 南京博讯国际展览有限公司 协办单位: 联系单位: 南京博讯国际展览有限公司 联 系 人: 李源 邮件地址: 1623105095@qq.com 联系电话: 010-51296171 / 15600508728 联系传真: 参展范围: 制药设备展 原料药设备 医药包装机械 实验室装备 制药用水设备 制冷设备 流体设备及洁净系统 展会优势 展会宣传推广: 160个影响力的媒体宣传 直邮邀请函180,000份 直销电邮推广 经销商集散地大量广告 传真、电话、短信推广 同类展会直接推介 展前举行展览推介会 买家服务中心一对一推广 与有关商会、协会合作 目标观众: 化药、中药、生化药、生物制品、动物药、农药、原料药/中间体 生物技术、生物工程、基因工程、细胞工程、蛋白、疫苗 食品、食品添加剂、营养/保健品、饮料、乳制品、奶制品、啤酒、白酒 产业园区、科研机构、大学院校等生产企业高管、相关政府、国内外贸易组织参观、参会 技术交流会: 展会期间,展会组委会将协助国内外参展企业在展馆会议室举办技术交流讲座,内容由企业自定,每场听众60-80人,由企业自行邀请,组委会协助组织,将讲座题目、主要内容和主讲人提交组委会。技术交流讲座场次有限,报满为止,每场讲座30分钟,费用9800元/场。 参展事项 展位类型及费用: 标准展位(3M×3M):国内企业¥12800元/个;双开口展位¥13800元/个;国外企业$3800美元/个。 豪华展位(3M×3M):豪华展位¥15800元/个;国外企业$4500美元/个。 微特展位(3M×6M):¥35800/个;国外企业$6800美元/个;(微型特装由组委会进行搭建,特殊用电费用由企业自付) 净空地(36㎡起租):国内企业¥1300/㎡;国外企业$380/㎡。 会刊广告: 封面¥30000 封二¥20000 封三¥10000 封底¥20000 彩色内页¥3000元/版 黑白内页¥1000元/版 其他广告: 参观券¥20000/万张 请柬¥10000/千张 升空球¥12000/个 拱门¥12000/个 胸牌¥20000/万个 手提袋¥10000/千个 赞助项目: 答谢晚宴及颁奖仪式、资料袋、胸牌及挂带、礼品等,详情请与展览会办公室联系。 展览会办公室: 南京博讯国际展览有限公司 联系人:李源 电话:010-51296171 / 15600508728 邮箱:1623105095@qq.com 地址:北京市密云区鼓楼东大街3号山水大厦4层 邮编:100085
广州市 | 琶洲保利世贸博览馆
2024.09.0809.10
2024中国(西安)生物医药及技术装备展览会
已结束
China (Xi 'an) Biomedical and Technical Equipment Exhibition 2024 Industry Field: Biomedical Industry, Technology Equipment Industry Conference Type: Exhibition, Trade Fair, Industry Summit Conference Theme: Promoting the Development of Biomedical Industry, Focusing on Innovation and Technology Conference Name: China (Xi 'an) Biomedical and Technical Equipment Exhibition 2024 Basic Information Exhibition Date: September 26-28, 2024 Exhibition City: Xi'an, China Detailed Address: China·Xi'an Lingkong Exhibition Center (1) Organizer: Zhongkai Exhibition Group, Shaanxi Provincial Pharmaceutical Association, Shaanxi Provincial Health Management Industry Promotion Association Supporting Units: Shaanxi Xianyang New Area Hongqiao New Town Management Committee Shaanxi Provincial Pharmaceutical Quality Association United Front Party Committee of Health and Health Care Industry Social Organizations at the Provincial Level, Shaanxi Province Cooperating Institutions: School of Medicine, Northwest University Fourth Military Medical University Xi'an Biopharmaceutical Technology Vocational Technical College **Strategic Cooperation Partner: Shaanxi Provincial Exhibition Group Implementing Units: Zhongkai International Exhibition (Beijing) Co., Ltd. Shaanxi Zhongkai Bowen Exhibition Co., Ltd. Contact Person: Liu Manager Phone Number: 186 0078 0506 Exhibition Overview The China (Xi 'an) Biomedical and Technical Equipment Exhibition 2024, organized by the Shaanxi Provincial Pharmaceutical Association and the Shaanxi Provincial Health Management Industry Promotion Association, and co-organized by Shaanxi Zhongkai Bowen Exhibition Co., Ltd., will be held at the Xi'an Lingkong Exhibition Center from September 26 to 28, 2024. The exhibition will continue to adhere to the development concept of openness, innovation, cooperation, and win-win, continuously explore and break through the innovation and development of biomedical technology and industry, promote the development of the medical device industry, and create a leader in the innovation of China's biomedical industry. It will integrate various activities such as exhibition display, annual innovation product selection and award, summit forum, new product launch, procurement conference, and training exchange, and strive to create the most advanced platform for showcasing and promoting the biomedical and related industries to the whole country and even the world. Product Scope Biopharmaceutical Ingredients Exhibition Area Chemical Pharmaceutical and Raw Materials Exhibition Area Biopharmaceutical Technology Exhibition Area Biopharmaceutical Products and Achievements Exhibition Area Pharmaceutical Equipment and Packaging Technology Exhibition Area Biochemical Instruments and Laboratory Equipment Exhibition Area Biopharmaceutical R&D, Manufacturing Technical Services Exhibition Area Biopharmaceutical Industrial Park and Development Policy Exhibition Area Biopharmaceutical Talent Exchange Exhibition Area Concurrent Activities China Biomedical Development Forum Chemical Drug Intelligent Manufacturing and Quality Control Technology Forum China Pharmaceutical Equipment & Scientific Instrument New Product Show and Exchange Conference Pharmaceutical Industry Technology Innovation and Industrial Development Seminar New Drug Research and Development and Project Evaluation Special Forum National Pharmaceutical Alliance Conference Exhibition Fees Outdoor Open Space: Starting from 18㎡, RMB 800 yuan/㎡ for domestic enterprises Standard Booth: 3m×3m, RMB 8800 yuan/9㎡ Deluxe Booth: RMB 10800 yuan/9㎡ Booth Heightening, Signboard Logo Production, Negotiation Round Table, etc. Important Notes After registration, the exhibitors must transfer the relevant fees to the designated account of the organizing committee within 3 working days. The arrangement of booth space is based on the principle of "first registered, first paid, first arranged", and the organizing committee reserves the right to adjust a small number of booth spaces.
西安市 | 西安
2024.09.2609.28
第十七届(2024秋季)药品质量安全大会(北京站)
已结束
第十七届(2024秋季)药品质量安全大会(北京站)会议邀请 基本信息 行业领域: 制药行业、药品质量安全 会议类型: 行业大会、学术研讨会 会议主题: 推动药品质量安全技术发展,提升行业质量管理水平 会议名称: 第十七届(2024秋季)药品质量安全大会(北京站) 会议详情 会议时间: 2024年9月6日至2024年9月7日 会议地点: 北京朗丽兹西山花园酒店 组织机构 指导单位: 中国社科院食品药品产业发展与监管研究中心 主办单位: 北京药之典信息技术中心 / 北京中培科检信息技术中心 承办单位: 药安汇信息技术(北京)有限公司 / 药安会信息技术(怀来)有限公司 参会信息 参会人员: 待定 参会费用: 日期 会议名称 票种 现场缴费 会前办款 说明 9月6-7日 药品质量安全大会 A类票 免费 免费 1.免费票仅1000张,先到先得2.参与集赞,可获【药安会】学习平台会员 9月6-7日 药品质量安全大会 B类票 800元 600元 1.含讲师授权课件、两天的会议午餐、平台个人会员2.参与集赞,可享200元优惠 联系方式 参展与赞助: 李光 18618307022(同微信) 参会与报名: 李晓 13651274249(同微信)
北京市 | 朗丽兹西山花园酒店
2024.09.0609.07
2024中国(西安)生物医药及技术装备展览会
已结束
China (Xi 'an) Biomedical and Technical Equipment Exhibition 2024 Basic Information Exhibition Date: September 26-28, 2024 Location: Xi'an International Airport Convention Center (1) Organizer: Zhongkai Exhibition Group, Shaanxi Provincial Pharmaceutical Association, Shaanxi Provincial Health Management Industry Promotion Association Supporting Units: Shaanxi Xianyang New Area Management Committee, Shaanxi Provincial Pharmaceutical Quality Association, United Front Committee of Health and Health Industry Social Organizations at the Provincial Level in Shaanxi Province Cooperating Institutions: School of Medicine, Northwest University, Fourth Military Medical University Strategic Partner: Shaanxi Exhibition Group Executive Units: Zhongkai International Exhibition (Beijing) Co., Ltd., Shaanxi Zhongkai Bowen Exhibition Co., Ltd. Exhibition Overview Add momentum to the innovative development of biomedicine —— Strengthening and expanding the bio-economy The "14th Five-Year Plan" and the long-term plan for the years 2035 propose to accelerate the development of the biopharmaceutical, bioresearch, biomaterials, bioenergy industries, and to strengthen and expand the bio-economy. The biopharmaceutical industry is a strategic emerging industry related to the national economy, people's livelihood, and national security, covering many aspects such as biotechnology industry, pharmaceutical industry, and biomedical engineering industry. In recent years, under the guidance of favorable policies, China's biopharmaceutical industry has entered a "fast lane" of development. A series of new products and services have provided new assistance for ensuring people's health and life. In terms of the industry, the research and development investment of the entire industry has increased significantly, with thousands of new drugs entering clinical trials, hundreds of new drugs conducting international multi-center clinical trials, and an increasing number of new drugs being approved. In terms of enterprises, traditional pharmaceutical enterprises are accelerating their transformation and innovation, and a large number of emerging biotechnology companies are being established and growing rapidly. These innovative entities are an important force in promoting the innovative development of biomedicine. As of the end of 2022, there were 4,120 biopharmaceutical-related enterprises in Xi'an High-Tech Zone, and the scale of the biopharmaceutical industry exceeded 60 billion yuan, ranking among the top in the national high-tech zones in the central and western regions. The China (Xi'an) Biomedical and Technical Equipment Exhibition, jointly organized by the Shaanxi Provincial Pharmaceutical Association, the Shaanxi Provincial Health Management Industry Promotion Association, and hosted by Shaanxi Zhongkai Bowen Exhibition Co., Ltd., will be held at the Xi'an International Airport Convention Center from September 26 to 28, 2024. The exhibition will continue to adhere to the development concept of openness, innovation, cooperation, and win-win, constantly explore and break through the innovation and development of biopharmaceutical technology and industry, promote the development of the medical device industry, and build a leader in the innovative development of China's biopharmaceutical industry. It will fully integrate various activities such as exhibition and display, annual innovation product selection and award, summit forum, new product launch, procurement conference, and training exchange, and strive to build the most advanced platform for showcasing and promoting biopharmaceutical and related industries to the whole country and even the world. Booth Scope Biopharmaceutical Ingredients Exhibition Area Chemical Pharmaceutical and Raw Materials Exhibition Area Biopharmaceutical Technology Exhibition Area Biopharmaceutical Products and Achievements Exhibition Area Pharmaceutical Equipment and Packaging Technology Exhibition Area Biochemical Instruments and Laboratory Equipment Exhibition Area Biopharmaceutical Research and Manufacturing Technical Services Exhibition Area Biopharmaceutical Industrial Park and Development Policy Exhibition Area Biopharmaceutical Talent Exchange Exhibition Area Concurrent Activities China Biomedical Development Forum Chemical Drug Intelligent Manufacturing and Quality Control Technology Forum China Pharmaceutical Equipment & Scientific Instrument New Product Show and Exchange Conference Pharmaceutical Industry Technological Innovation and Industrial Development Seminar New Drug Research and Development and Project Evaluation Special Forum National Pharmaceutical Union Conference Fees Outdoor Open Space: Starting from 18㎡, domestic enterprises: RMB 800 yuan/㎡ Standard Booth: 3m×3m, RMB 8,800 yuan/9㎡ Deluxe Booth: 10800 yuan/9㎡ (additional charges for booth heightening, signboard logo making, negotiation round table, etc.) Professional Visitors Fermentation engineering, bioengineering, synthetic biology, pharmaceuticals, life sciences, cellular engineering, protein engineering, biopharmaceuticals, bioprocessing, biofeed, biopesticides, biofertilizers, biorefinery, energy conservation and environmental protection, health nutrition products, etc. Sales, procurement, technology, research and development, design, engineering companies; design institutes, universities, and related scientific research institutions in life sciences and biotechnology; CXO enterprises, OEM/ODM service enterprises, raw material manufacturers; professional research and development elites, technical experts, corporate executives, marketing elites, bioprocessing, biopharmaceutical-related research, production, equipment, sales enterprises, biopharmaceutical industry; vaccine, antibody companies, biotechnology companies, research institutions, hospitals, laboratories, and environmental protection, investment and financing institutions; logistics providers, cold chain packaging companies, distributors, laboratory equipment providers, industrial parks; other truss spray Tickets Logo banner: 20000 yuan/standard span Ticket/ID card: 5000 yuan/each Drinking water: 2000 yuan/10,000 bottles Important Notes After registration, the exhibiting units must transfer the relevant fees to the designated account of the organizing committee within 3 working days. The arrangement of booth space is based on the principle of "first registration, first payment, first arrangement". The organizing committee reserves the right to adjust a small number of booth spaces. Contact Information Address: No. 15, Guangren West Road, Xianyang New Area, Xianyang New Area Contact Person: Manager Liu, 186 0078 0506
西安市 | 西安
2024.09.2609.28
IGC 2024第八届免疫基因及细胞治疗大会
已结束
IGC2024第八届免疫基因及细胞治疗大会 行业领域: 免疫基因治疗、细胞治疗 会议类型: 大会、学术研讨会、行业峰会 会议主题: 探讨免疫基因及细胞治疗领域的热点议题,促进产学研医合作 会议名称: IGC2024第八届免疫基因及细胞治疗大会 基本信息 参展时间: 2024年9月5日至2024年9月7日 展会城市: 中国北京市 详细地址: 北京国际会议中心 主办单位: [待补充] 承办单位: [待补充] 协办单位: [待补充] 联系单位: [待补充] 联 系 人: [待补充] 邮件地址: igc@bmapglobal.com 联系电话: +86 13122785593 联系传真: [待补充] 大会亮点 大咖云集: 邀请了国内外知名专家和学者,如程涛、沈琳、Kenji Osafune等,共同探讨免疫基因及细胞治疗领域的最新进展。 全新亮点: 从产业策略、学术交流到产业化实践,涵盖基因编辑、合成生物学、iPSC、LNP-mRNA、外泌体、AAV等前沿技术。 大会结构: 包括主题演讲、分会场讨论、展览展示等多种形式,为参会者提供丰富的交流平台。 参会群体: 覆盖工业界、科研院校、医院临床、上游供应商、政府/监管机构等多个领域。 参会理由 北方最具规模影响力的CGT行业盛会: 汇聚行业领袖,提供一站式交流平台。 融合荟萃: 融合科研界、工业界、临床界、资本端等资深参会观众。 优质解决方案: 百家行业知名仪器设备、技术服务及原料试剂耗材参展商出席。 聚焦热点: 聚焦体内细胞治疗、通用型细胞治疗、CAR-NK、TILs、iPSC干细胞治疗、基因编辑治疗、AAV基因治疗等热点增长版块。 联系组委会 电话: +86 13122785593 邮箱: igc@bmapglobal.com
北京市 | 国际会议中心
2024.09.0509.07
2024中国国际辅助生殖大会
已结束
中国国际辅助生殖大会 行业领域: 生殖医学、辅助生殖技术 会议类型: 学术会议、研讨会、国际论坛 会议主题: 创造生命奇迹(Create the Miracle of Life) 会议名称: 中国国际辅助生殖大会 基本信息 参展时间: 2024年9月25日至2024年9月26日 展会城市: 中国上海市 详细地址: [待定] 展馆名称: [待定] 主办单位: 广州新式会展服务有限公司 承办单位: 协办单位: 中国保健协会生殖健康分会、浙江省健康产业研究会生殖健康专业委员会 联系单位: 联 系 人: [待定] 邮件地址: 联系电话: [待定] 联系传真: 会议议程 主题论坛一:男性不孕症治疗与男性生育管理 主题: 非梗阻性无精子症候选致病基因的研究和临床检测意义 嘉宾: 孙斐—浙江大学医学院附属邵逸夫医院特聘教授 主题: R-loops在配子发生过程中的功能与作用机制 嘉宾: 李卫—广州市妇女儿童医疗中心研究员 主题: 精子发生障碍临床分型诊治探讨 嘉宾: 李铮—上海市第一人民医院教授 主题: 精子发生障碍与男性不育 嘉宾: 赵小阳—南方医科大学二级教授 主题: 男性不育的分子机理(暂定) 嘉宾: 肖骧—杭州医学院药学院副研究员 主题论坛二:女性不孕症和生育力保护 主题: Treatment of patients with recurrent unsuccessful IVF - complex and multidisciplinary task 嘉宾: Zorina Irina Vadimovna (佐里娜·伊琳娜·瓦迪莫夫娜) — Balchug Clinic Director 主题: 冻卵保存女性生育力现状分析 嘉宾: 韩毅冰—澳门镜湖医院教授 主题: 评估优化不孕妇女妊娠结局的干预措施和辅助治疗 嘉宾: 叶虹—重庆市妇幼保健院主任医师 主题: 女性生殖内分泌调控 (暂定) 嘉宾: 陈秋菊—上海第九人民医院副研究员 主题: 优化辅助受孕女性胚胎移植结局的干预措施 嘉宾: 王晓红—空军军医大学唐都医院教授 主题: 卵子IVM与生育力保存 嘉宾: 千日成—同济大学附属第十人民医院教授 主题: 待定 嘉宾: 何茶英—杭州师范大学附属医院主任医师 主题论坛三:干细胞在生殖中的应用 主题: 人早期胚胎与基于干细胞的类胚胎发育调控机制研究 嘉宾: 高绍荣—同济大学特聘教授 主题: 经血干细胞在治疗生殖障碍疾病中的研究进展 嘉宾: 谭季春—中国医科大学附属盛京医院主任医师 主题: 干细胞治疗卵巢早衰基础与临床研究 嘉宾: 赖东梅—附属国际和平妇幼保健院主任医师 主题: 干细胞体外配子分化诱导 嘉宾: 沙家豪—生殖医学与子代健康全国重点实验室教授 主题: 干细胞治疗卵巢早衰及宫腔粘连的临床前研究及转化应用 嘉宾: 徐韶华—同济大学附属第一妇婴保健院主任医师 主题论坛四:跨境生殖医学 主题: 美国的辅助生殖优势 嘉宾: [待定] 主题: 日本的辅助生殖优势 嘉宾: Shingo Fujii — 日本Kitano医院 Director 主题: 台湾的辅助生殖优势 嘉宾: 沈宗奇 — 上海禾新医院 副主任医师 主题: Cross-border reproductive care and deltaFertility in Russia and Kyrgyzstan 嘉宾: Bakhtina Anna — CEO of Delta Fertility Clinic 主题: 格鲁吉亚的辅助生殖优势 嘉宾: Naia Adamia — InvitroLife IVF Clinic Director 主题: 土耳其的辅助生殖优势 嘉宾: Hakan Yarali — Anatolia IVF Director 主题论坛五:辅助生殖技术创造生命的奇迹 主题: 罕见不孕症的诊疗及不孕症IVF-ET治疗方案(暂定) 嘉宾: 芦雪峰—上海第九人民医院教授 主题: 有关高龄助孕的思考及对策 (暂定) 嘉宾: 纪亚忠—上海市同济医院教授 主题: 待定 嘉宾: 叶卡捷丽娜·马利巴霍娃—俄罗斯莫斯科NGC生殖助孕医院医学副博士 主题: 基于早产发生机制的精准临床综合防控策略研究 (暂定) 嘉宾: 应豪—同济大学附属第一妇婴保健院教授 主题: Con la vitrificación de óvulos, las mujeres pueden decidir cuándo ser madres sin perder la calidad del óvulo 嘉宾: Ramón Aurell Ballesteros—Quirónsalud Barcelona Hospital Director 嘉宾持续邀约中,议程待更新...
浦东新区 | 上海浦东绿地假日酒店
2024.09.2509.26